Eko Suhartono
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Eko Suhartono has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Adenan Adenan
1 shared publicationAri Yunanto
1 shared publicationBambang Setiawan
Department of Medical Chemistry-Center for Free Radical and Natural Product Studies Lambung Mangkurat University School of Medicine Banjarbaru
1 shared publicationDanny Indrawardhana
Banjarbaru Hospital, Banjarbaru of South Kalimantan, Indonesian
1 shared publicationElla Viani
Graduate School of Medicine, Lambung Mangkurat of University, South Kalimantan, Indonesian
1 shared publicationImam Syahuri Gultom
Graduate School of Medicine, Lambung Mangkurat of University, South Kalimantan, Indonesian
1 shared publication
Latest Publications
- Open Access
- 13 December 2012
- Published by Elsevier in APCBEE Procedia
- Vol. 4, 235-239
Total flavonoid and Antioxidant Activity of Some Selected Medicinal Plants in South Kalimantan of Indonesian
- 13 December 2012
- Published by Elsevier in APCBEE Procedia
- Vol. 4, 235-239
Open AccessTotal flavonoid and Antioxidant Activity of Some Selected Medicinal Plants in South Kalimantan of Indonesian
- Open Access
- 18 January 2007
- Published by Lembaga Penelitian Universitas YARSI in Jurnal Kedokteran YARSI
- Vol. 15 (1)
Antioksidatif estrogen dalam menghambat advanced oxidation protein product akibat reaksi glikosilasi
Ethinyl estradiol is an estrogen derivative used as contraceptive or hormone replacement therapy to maintain woman’s sexual function. The aim of this study was to examine ethinyl estradiol antioxidative activity and its potency to inhibit protein oxidation by glycocylation reaction. This study was an in vitro assay and its antioxidative activity by H2O2 scavenging, •OH scavenging, metal chelating were measured. Activity as inhibitor of Advanced Oxidation Protein Products (AOPP) was carried out by using glycocylation reaction. Three groups (n=6), i.e P0 control (3 ml of serum), P1 (3 ml of serum + glucose 500 mM), and P2 (3 ml of serum + glucose 500 mM + ethinyl estradiol 0,15gr/100mL) were used in this study. The result of this study showed that H2O2 scavenging, •OH scavenging, metal chelating were 48,889%, 15,139%, 11,538% respectively. For AOPP inhibition, P0 and P1 was different significantly (p0,05), and P1 and P2 was different significantly (p<0,05). It was suggested that antioxidative mechanism from ethinyl estradiol could inhibit AOPP formation generated by glycocylation reaction.
- 18 January 2007
- Published by Lembaga Penelitian Universitas YARSI in Jurnal Kedokteran YARSI
- Vol. 15 (1)
Open AccessAntioksidatif estrogen dalam menghambat advanced oxidation protein product akibat reaksi glikosilasi
Ethinyl estradiol is an estrogen derivative used as contraceptive or hormone replacement therapy to maintain woman’s sexual function. The aim of this study was to examine ethinyl estradiol antioxidative activity and its potency to inhibit protein oxidation by glycocylation reaction. This study was an in vitro assay and its antioxidative activity by H2O2 scavenging, •OH scavenging, metal chelating were measured. Activity as inhibitor of Advanced Oxidation Protein Products (AOPP) was carried out by using glycocylation reaction. Three groups (n=6), i.e P0 control (3 ml of serum), P1 (3 ml of serum + glucose 500 mM), and P2 (3 ml of serum + glucose 500 mM + ethinyl estradiol 0,15gr/100mL) were used in this study. The result of this study showed that H2O2 scavenging, •OH scavenging, metal chelating were 48,889%, 15,139%, 11,538% respectively. For AOPP inhibition, P0 and P1 was different significantly (p0,05), and P1 and P2 was different significantly (p<0,05). It was suggested that antioxidative mechanism from ethinyl estradiol could inhibit AOPP formation generated by glycocylation reaction.